SEARCH Clinical Trial: 80 mg Simvastatin Zocor, Kidney Damage, Muscle Damage
In March 2010, the FDA made an announcement based on the SEARCH (Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine clinical trial. Based on this data, the FDA informed the public about an increased risk of muscle injury in patients who take the highest approved dose of the cholesterol-lowering medication, (generic: simvastatin) Zocor 80 mg. The risk was compared to patients taking lower doses of simvastatin and possibly other drugs in the statin drug class.
Currently, the FDA is reviewing data from other clinical trials, observational studies, adverse event reports, and prescription use of simvastatin to comprehend the relationship between high-dose simvastatin and muscle injury.
Simvastatin is sold as a single-ingredient generic medication under the brand-name, Zocor. It is also sold in combination with ezetimibe as Vytorin and niacin as Simcor.
Muscle injury, also called myopathy, is a known side effect with all statin medications. The most serious form of myopathy is called rhabdomyolysis which occurs when a protein (myoglobin) is released as muscle fibers break down. Patients with rhabdomyolysis may have dark or red urine and fatigue, in addition to their muscle symptoms.
Damage to the kidneys from rhabdomyolysis can be so severe that patients may develop kidney failure which can be fatal...all from taking a cholesterol-lowering medicine prescribed to lower your cholesterol.
What's wrong with that picture?
Have you or family member developed serious muscle damage from taking 80 mg simvastatin?
Have you or family member developed serious kidney damage from taking 80 mg simvastatin?
The Pennsylvania Bulldog Lawyers are a tenacious breed. Find out how the Pa. Bulldog Lawyers can help you determine if you have a Zocor injury lawsuit.
